Reduced Glu–Gln levels, GS activity, Glu–Gln cycle protein expression levels, and sEPSC in the mPFC were also not observed in Gln-supplemented mice after CIS, nor were neuronal cell damages [20,29,30]. Here, GLUL is linked to in situ carcinoma.